Susan Manzi

Susan Manzi

UNVERIFIED PROFILE

Are you Susan Manzi?   Register this Author

Register author
Susan Manzi

Susan Manzi

Publications by authors named "Susan Manzi"

Are you Susan Manzi?   Register this Author

100Publications

2790Reads

-Profile Views

Current challenges in the development of new treatments for lupus.

Ann Rheum Dis 2019 Jun 12;78(6):729-735. Epub 2019 Jan 12.

RILITE Research Institute, Charlottesville, Virginia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-214530DOI Listing
June 2019

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

J Rheumatol 2019 May 15;46(5):492-500. Epub 2019 Jan 15.

From the Rheumatology/Division of Neuro and Inflammation Sciences, Department of Clinical and Experimental Medicine, Linköping University, Linköping; Department of Medicine, Unit of Rheumatology, Karolinska Institutet and Karolinska University Hospital, Stockholm; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund; Unit for Clinical Therapy Research (ClinTRID), Karolinska University, Stockholm, Sweden; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario; Division of Rheumatology, Centre Hospitalier Universitaire (CHU) de Québec - Université Laval, Quebec City, Quebec; Division of Rheumatology, Cumming School of Medicine - University of Calgary, Calgary, Alberta; Division of Rheumatology, Department of Medicine, McGill University Health Centre, Montreal, Quebec; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia; Department of Medicine and Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham; Centre for Rheumatology Research, University College, London; Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, King's College London School of Medicine, London; Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester and UK National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester University Foundation Trust, Manchester, UK; Cedars-Sinai/David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, California; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Department of Medicine, State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama; Department of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Feinstein Institute for Medical Research, Manhasset, New York; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina; Autoimmunity Institute, Allegheny Health Network, Pittsburgh, Pennsylvania; Northwestern University and Feinberg School of Medicine, Chicago, Illinois; Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia; University of California San Diego School of Medicine, La Jolla, California; Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina; Division of Rheumatology, Columbia University Medical Center, New York, New York, USA; Department of Rheumatology, Center for Rheumatology Research Fossvogur Landspitali University Hospital, Reyjkavik, Iceland; Autoimmune Disease Unit, Department of Internal Medicine, Hospital Universitario Cruces, BioCruces Health Research Institute, University of the Basque Country, Barakaldo; Josep Font Autoimmune Diseases Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Copenhagen Lupus and Vasculitis Clinic, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Rheumatology, Kantousspital, Schaffhausen, Switzerland.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.180713
Publisher Site
http://dx.doi.org/10.3899/jrheum.180713DOI Listing
May 2019

Construction of a frailty index as a novel health measure in systemic lupus erythematosus.

J Rheumatol 2019 Apr 15. Epub 2019 Apr 15.

Department of Medicine, Division of Rheumatology, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada; Division of Geriatric Medicine, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea;Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Instituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico; Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Divisions of Rheumatology and Clinical Epidemiology, Department of Medicine, McGill University, Montreal, Quebec, Canada; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA; Division of Rheumatology, CHU de Québec et Université Laval, Quebec City, Canada; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, ON, Canada; Arthritis Research UK Epidemiology Unit, Faculty of Biology Medicine and Health, Manchester Academic Health Sciences Center, The University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Center Manchester, UK; Center for Rheumatology, Department of Medicine, University College London, UK; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, UK, London, UK; Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, USA; Northwestern University and Feinberg School of Medicine, Chicago, IL, USA; Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, PA, USA; Lanarkshire Center for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland UK; Feinstein Institute for Medical Research, Manhasset, NY, USA; Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain; Emory University School of Medicine, Division of Rheumatology, Atlanta, Georgia, USA Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Unit for clinical therapy research (ClinTRID), Karolinska Institute, Stockholm, Sweden; Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden. Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Medical University of South Carolina, Charleston, South Carolina, USA; UCSD School of Medicine, La Jolla, CA, USA; Copenhagen Lupus and Vasculitis Clinic, 4242, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; University of Manitoba, Winnipeg, Manitoba, Canada; Hospital for Joint Diseases, NYU, Seligman Center for Advanced Therapeutics, New York NY; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada. Funding for this work was provided by the Nova Scotia Health Authority Research Fund. Dr. Sang-Cheol Bae's work was supported in part by NRF-2017M3A9B4050335, Republic of Korea. Dr. Caroline Gordon's work was supported by Lupus UK and the NIHR /Wellcome Trust Clinical Research Facility. The Montreal General Hospital Lupus Clinic is partially supported by the Singer Family Fund for Lupus Research. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Paul R. Fortin presently holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases at Université Laval, and part of this work was done while he was still holding a Distinguished Senior Investigator of The Arthritis Society. Dr. Bruce is a National Institute for Health Research (NIHR) Senior Investigator and is supported by Arthritis Research UK, the NIHR Manchester Biomedical Centre and the NIHR/Wellcome Trust Manchester Clinical Research Facility. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. Dr Isenberg and Dr Rahman are supported by and supported by the National Institute for Health, Research University College London Hospitals Biomedical Research Center. The Hopkins Lupus Cohort is supported by the NIH (grant AR43727 and 69572). Dr. Mary Anne Dooley's work was supported by the NIH (grant RR00046). Dr. Ramsey-Goldman's work was supported by the NIH (grants 5UL1TR001422-02, formerly 8UL1TR000150 and UL-1RR-025741, K24-AR-02318, and P60AR064464 formerly P60-AR- 48098). Dr. Ruiz-Irastorza is supported by the Department of Education, Universities and Research of the Basque Government. Dr. Soren Jacobsen is supported by the Danish Rheumatism Association (A3865) and the Novo Nordisk Foundation (A05990). Dr. John G. Hanly is supported by the Canadian Institutes of Health Research (grant MOP-88526). Address Correspondence to: Dr. John G Hanly, Division of Rheumatology, Nova Scotia Rehabilitation Centre (2nd Floor), 1341 Summer Street, Halifax, Nova Scotia, Canada, B3H 4K4.Email:

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.181338
Publisher Site
http://dx.doi.org/10.3899/jrheum.181338DOI Listing
April 2019

Cell-bound complement activation products as lupus biomarkers: diagnosis, monitoring and stratification.

Expert Rev Clin Immunol 2017 12 6;13(12):1133-1142. Epub 2017 Nov 6.

a Lupus Center of Excellence , Autoimmunity Institute, Allegheny Health Network , Pittsburgh , PA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1744666X.2017.1392238DOI Listing
December 2017

Editorial: Lupus, the Chameleon: Many Disguises Difficult to Capture.

Arthritis Rheumatol 2017 10 10;69(10):1921-1924. Epub 2017 Sep 10.

Oklahoma Medical Research Foundation, Oklahoma City.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.40190DOI Listing
October 2017

Association of aortic perivascular adipose tissue density with aortic calcification in women with systemic lupus erythematosus.

Atherosclerosis 2017 07 29;262:55-61. Epub 2017 Apr 29.

Lupus Center of Excellence, Autoimmunity Institute, Department of Medicine, Allegheny Health Network, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2017.04.021DOI Listing
July 2017

Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices.

J Rheumatol 2015 Dec 1;42(12):2288-95. Epub 2015 Nov 1.

From the Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; New York University Langone Medical Center; Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center, New York; Hofstra North Shore-LIJ School of Medicine, Hempstead, New York; Medical University of South Carolina, Charleston, South Carolina; Temple University School of Medicine, Philadelphia, Pennsylvania; Johns Hopkins University School of Medicine, Baltimore, Maryland; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Karolinska University Hospital, Stockholm, Sweden; Cedars-Sinai Medical Center, Los Angeles, California, USA.J.S. Hui-Yuen, MD, MSc, Fellow, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; A. Reddy, BSc, Research Assistant, New York University Langone Medical Center; J. Taylor, MD, Pediatric Resident, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; X. Li, BSc, Research Assistant, Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center; A.H. Eichenfield, MD, Assistant Professor, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; L.M. Bermudez, MD, Fellow, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; A.J. Starr, MD, Assistant Professor, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; L.F. Imundo, MD, Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center; J. Buyon, MD, Professor, New York University Langone Medical

View Article

Download full-text PDF

Source
http://www.jrheum.org/cgi/doi/10.3899/jrheum.150470
Publisher Site
http://dx.doi.org/10.3899/jrheum.150470DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031077PMC
December 2015

Cardiovascular disease biomarkers across autoimmune diseases.

Clin Immunol 2015 Nov 11;161(1):59-63. Epub 2015 Jul 11.

Lupus Center of Excellence, Autoimmunity Institute, Department of Medicine, Allegheny Health Network, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2015.05.024DOI Listing
November 2015

Antilymphocyte autoantibodies generate T cell-C4d signatures in systemic lupus erythematosus.

Transl Res 2014 Dec 7;164(6):496-507. Epub 2014 Aug 7.

Lupus Center of Excellence, Autoimmunity Institute, Allegheny-Singer Research Institute, Allegheny Health Network, Pittsburgh, PA; Temple University School of Medicine, Pittsburgh, PA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S19315244140027
Publisher Site
http://dx.doi.org/10.1016/j.trsl.2014.07.007DOI Listing
December 2014

The lupus biomarker odyssey: one experience.

Methods Mol Biol 2014 ;1134:17-35

Asthma Allergy and Autoimmunity Institute, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-0326-9_2DOI Listing
September 2014

Relation of platelet C4d with all-cause mortality and ischemic stroke in patients with systemic lupus erythematosus.

Transl Stroke Res 2014 Aug 27;5(4):510-8. Epub 2013 Oct 27.

Lupus Center of Excellence, Allegheny Health Network, North Tower, Suite 2600, 4800 Friendship Avenue, Pittsburgh, PA, 15224, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12975-013-0295-9DOI Listing
August 2014

American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohort.

J Rheumatol 2014 May 1;41(5):875-80. Epub 2014 Apr 1.

From the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada; Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Department of Rheumatology, Hospital for Rheumatic Diseases and Hanyang University Medical Center, Seoul, Korea; Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Montreal General Hospital and McGill University Health Centre, Montreal, Quebec, Canada; Centre Hospitalier Universitaire de Québec et Université Laval, Quebec City, Quebec, Canada; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada; Centre for Rheumatology Research, University College, London, UK; Cedars-Sinai/David Geffen School of Medicine, University of California, Los Angeles, California, USA; Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York, USA; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA; Department of Rheumatology, University Hospital Lund, Lund, Sweden; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama, USA; Center for Rheumatology Research, Landspitali University Hospital, Reyjkavik, Iceland; Northwestern University and Feinber

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130704DOI Listing
May 2014

Updated review of complementary and alternative medicine treatments for systemic lupus erythematosus.

Curr Rheumatol Rep 2013 Nov;15(11):378

UPMC Shadyside Center for Integrative Medicine, University of Pittsburgh School of Medicine, 580 South Aiken Avenue, Suite 310, Pittsburgh, PA, 15232, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11926-013-0378-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898893PMC
November 2013

Perivascular adipose tissue of the descending thoracic aorta is associated with systemic lupus erythematosus and vascular calcification in women.

Atherosclerosis 2013 Nov 11;231(1):129-35. Epub 2013 Sep 11.

Lupus Center of Excellence, West Penn Allegheny Health System, 320 East North Avenue, Pittsburgh, PA 15212, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2013.09.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831349PMC
November 2013

Biomarkers in systemic lupus erythematosus: challenges and prospects for the future.

Ther Adv Musculoskelet Dis 2013 Aug;5(4):210-33

Allegheny Singer Research Institute,Temple University School of Medicine,320 East North Avenue Pittsburgh, PA 15212, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1759720X13485503DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728979PMC
August 2013

Genome-wide association study of antiphospholipid antibodies.

Autoimmune Dis 2013 24;2013:761046. Epub 2013 Feb 24.

Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/761046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595708PMC
March 2013

Biomarkers for systemic lupus erythematosus.

Transl Res 2012 Apr 10;159(4):326-42. Epub 2012 Feb 10.

Lupus Center of Excellence, Department of Medicine, Allegheny Singer Research Institute, West Penn Allegheny Health System and Temple University School of Medicine, 320 E. North Avenue, Pittsburgh, PA 15212, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trsl.2012.01.021DOI Listing
April 2012

Association between depression and vascular disease in systemic lupus erythematosus.

J Rheumatol 2012 Feb 15;39(2):262-8. Epub 2011 Dec 15.

Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.110327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335PMC
February 2012

A structured literature review of the direct costs of adult systemic lupus erythematosus in the US.

Arthritis Care Res (Hoboken) 2011 Sep;63(9):1224-32

Boston Healthcare Associates, Inc., Massachusetts 02110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.20502DOI Listing
September 2011

Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.

J Rheumatol 2010 Jun 1;37(6):1136-42. Epub 2010 May 1.

Department of Medicine, Division of Rheumatology, University of Pittsburgh, School of Nursing, 440 Victoria Street, Room 453B, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.090994DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457696PMC
June 2010

Functional and genetic characterization of the promoter region of apolipoprotein H (beta2-glycoprotein I).

FEBS J 2010 Feb 18;277(4):951-63. Epub 2010 Jan 18.

Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1742-4658.2009.07538.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860786PMC
February 2010

Cell-bound complement biomarkers for systemic lupus erythematosus: from benchtop to bedside.

Rheum Dis Clin North Am 2010 Feb;36(1):161-72, x

Lupus Center of Excellence, University of Pittsburgh School of Health Sciences, Pittsburgh, PA 15260, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2009.12.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837510PMC
February 2010

Cardiovascular risk assessment and treatment in systemic lupus erythematosus.

Best Pract Res Clin Rheumatol 2009 Aug;23(4):481-94

University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.berh.2009.03.005DOI Listing
August 2009

Atherosclerosis risk factors in systemic lupus erythematosus.

Curr Rheumatol Rep 2009 Aug;11(4):241-7

Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
August 2009

Lupus update: perspective and clinical pearls.

Authors:
Susan Manzi

Cleve Clin J Med 2009 Feb;76(2):137-42

Director, Patient Care and Translational Research, Lupus Center of Excellence, University of Pittsburgh School of Medicine and Graduate School of Public Health, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3949/ccjm.76a.gr005DOI Listing
February 2009

Platelet C4d is associated with acute ischemic stroke and stroke severity.

Stroke 2008 Dec 16;39(12):3236-41. Epub 2008 Oct 16.

University of Pittsburgh School of the Health Sciences, University of Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/STROKEAHA.108.514687DOI Listing
December 2008

Genetic variation in C-reactive protein (CRP) gene may be associated with risk of systemic lupus erythematosus and CRP concentrations.

J Rheumatol 2008 Nov 15;35(11):2171-8. Epub 2008 Sep 15.

Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582591PMC
November 2008

A model of integrated patient care and clinical translational research.

Clin Transl Sci 2008 Sep;1(2):96-8

Lupus Center of Excellence, University of Pittsburgh Schools of the Health Sciences and Magee-Women's Hospital of University of Pittsburgh Medical Center, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1752-8062.2008.00049.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439569PMC
September 2008

C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis.

Am J Cardiol 2008 Sep 26;102(6):755-60. Epub 2008 Jun 26.

Department of Medicine, Division of Rheumatology and Clinical Immunology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2008.04.059DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2563802PMC
September 2008

Risk of unintended pregnancy among women with systemic lupus erythematosus.

Arthritis Rheum 2008 Jun;59(6):863-6

University of Pittsburgh, Center for Research on Health Care, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.23712DOI Listing
June 2008

Genetic variation in the paraoxonase-3 (PON3) gene is associated with serum PON1 activity.

Ann Hum Genet 2008 Jan 25;72(Pt 1):72-81. Epub 2007 Sep 25.

Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1469-1809.2007.00400.x
Publisher Site
http://dx.doi.org/10.1111/j.1469-1809.2007.00400.xDOI Listing
January 2008

Self-reported fractures and associated factors in women with systemic lupus erythematosus.

J Rheumatol 2007 Oct 1;34(10):2018-23. Epub 2007 Sep 1.

Department of Medicine, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
October 2007

Association study of Toll-like receptor 5 (TLR5) and Toll-like receptor 9 (TLR9) polymorphisms in systemic lupus erythematosus.

J Rheumatol 2007 Aug 15;34(8):1708-11. Epub 2007 May 15.

Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.

View Article

Download full-text PDF

Source
August 2007

Mannose-binding lectin is a disease-modifying factor in North American patients with systemic lupus erythematosus.

J Rheumatol 2007 Jul 15;34(7):1506-13. Epub 2007 Jun 15.

Lupus Center of Excellence, University of Pittsburgh Schools of Health Sciences, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.

View Article

Download full-text PDF

Source
July 2007

Association between African American race/ethnicity and low bone mineral density in women with systemic lupus erythematosus.

Arthritis Rheum 2007 May;57(4):585-92

Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.22668DOI Listing
May 2007

The role of preventive cardiology in systemic lupus erythematosus.

Curr Rheumatol Rep 2007 May;9(2):125-30

University of Pittsburgh School of Medicine, S727 Biomedical Sciences Tower, 3500 Terrace Street, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
May 2007

Cell-bound complement activation products (CB-CAPs) as a source of lupus biomarkers.

Adv Exp Med Biol 2006 ;586:381-90

Lupus Center of Excellence, University of Pittsburgh School of Medicine, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/0-387-34134-X_25DOI Listing
February 2007

Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection.

J Clin Microbiol 2006 Oct;44(10):3734-41

Molecular Virology Program, University of Pittsburgh Cancer Institute, Hillman Cancer Research Pavilion Suite 1.8, 5117 Centre Avenue, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JCM.00191-06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1594766PMC
October 2006

Prevention of cardiovascular disease in patients with rheumatic diseases.

Best Pract Res Clin Rheumatol 2006 Aug;20(4):741-56

University of Pittsburgh, Division of Rheumatology and Clinical Immunology, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152169420600046
Publisher Site
http://dx.doi.org/10.1016/j.berh.2006.04.005DOI Listing
August 2006

Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide.

Nat Clin Pract Rheumatol 2006 Jul;2(7):354-5

Lupus Center of Excellence,University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncprheum0217DOI Listing
July 2006

Platelet C4d is highly specific for systemic lupus erythematosus.

Arthritis Rheum 2006 Feb;54(2):670-4

University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.21627DOI Listing
February 2006

Hormone therapy in systemic lupus erythematosus.

Curr Rheumatol Rep 2005 Dec;7(6):455-6; discussion 456

View Article

Download full-text PDF

Source
December 2005

Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus.

Arthritis Rheum 2005 Oct;52(10):3087-99

University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.21305DOI Listing
October 2005

Biomarkers for systemic lupus erythematosus: a review and perspective.

Curr Opin Rheumatol 2005 Sep;17(5):543-9

Lupus Center of Excellence, School of Health Sciences, University of Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
September 2005